| Recruiting | Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM) Breast Cancer | N/A | 2025-11-11 |
| Recruiting | Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancrea Pancreatic Cancer | N/A | 2024-05-01 |
| Recruiting | Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2024-01-30 |
| Recruiting | Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases Solid Tumor Spine Metastases | Phase 1 / Phase 2 | 2023-11-21 |
| Active Not Recruiting | Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-posit HER2-positive Breast Cancer | Phase 2 | 2023-10-26 |
| Terminated | PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancr Pancreatic Cancer | Phase 2 | 2023-05-31 |
| Active Not Recruiting | Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma Multiple Myeloma | Phase 2 | 2022-04-01 |
| Terminated | Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Colorectal Neoplasms, Stomach Neoplasm, Esophageal Neoplasms | Phase 1 | 2022-01-13 |
| Active Not Recruiting | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. Multiple Myeloma | Phase 1 | 2021-12-08 |
| Recruiting | 'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung) NSCLC/Oligometastatic Cancer (Single Lung Lesion) | Phase 2 | 2020-12-22 |
| Completed | Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-P Advanced Pancreatic Cancer | Phase 2 | 2020-10-16 |
| Terminated | The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to th Cancer, COVID-19 | — | 2020-04-29 |
| Terminated | Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive B HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer | Phase 1 | 2019-11-12 |
| Completed | Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian T Serous Ovarian Tumor, Endometrioid Carcinoma Ovary, Fallopian Tube Cancer | — | 2019-03-22 |
| Terminated | Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bo Castration-resistant Prostate Cancer, Metastatic Cancer, Bone Metastases | Phase 2 | 2019-01-09 |
| Completed | Identification of New Patient Stratification Tools in MSS RAS mt mCRC Advanced Colorectal Cancer | — | 2018-09-19 |
| Completed | The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Breast Cancer | — | 2017-03-16 |
| Terminated | INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2016-08-10 |
| Completed | CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey Cancer | — | 2016-05-01 |
| Completed | Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study HER2 Positive Breast Cancer | Phase 1 | 2016-04-01 |
| Completed | Neo-adjuvant Abiraterone Prostate Study High Risk Localised Prostate Carcinoma | Phase 2 | 2015-07-09 |
| Completed | Radium-223 in Combination With Enzalutamide Prostate Cancer | Phase 2 | 2015-06-03 |
| Completed | Irish Programme for Stratified Prostate Cancer Therapy Prostate Cancer | — | 2015-02-01 |
| Completed | Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myelo Multiple Myeloma | Phase 2 | 2014-11-01 |
| Terminated | Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer Locally Advanced Rectal Cancer | Phase 1 / Phase 2 | 2014-10-17 |
| Completed | A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or M Advanced Melanoma, Metastatic Melanoma | — | 2014-09-01 |
| Terminated | Plasma Biomarkers P-DAC, V1 Pancreatic Ductal Adenocarcinoma | — | 2014-05-26 |
| Active Not Recruiting | TAILORx Tissue Bank Breast Cancer | — | 2013-12-01 |
| Terminated | Plasma Biomarkers C-RAC, ICORG 12-27, V1 Colorectal Cancer | — | 2013-10-01 |
| Completed | ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer? Metastatic Breast Cancer | — | 2013-05-01 |
| Recruiting | Breast Cancer Proteomics and Molecular Heterogeneity Primary Breast Cancer, Recurrent/Metastatic Breast Cancer | — | 2013-02-01 |
| Completed | NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-A Adenocarcinoma of the Oesophagus, Adenocarcinoma of the Oesophago-gastric Junction, Oesophageal Tumours | Phase 3 | 2013-01-24 |
| Completed | ANGIOPREDICT. ICORG 12-16, V3 Advanced Colorectal Cancer | — | 2012-11-01 |
| Completed | Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer Breast Cancer, HER2 Positive Breast Cancer, HER2 Negative Breast Cancer | — | 2012-10-12 |
| Terminated | Ovarian Reserve in Premenopausal Breast Cancer Premenopausal Breast Cancer, Breast Cancer | — | 2012-09-01 |
| Terminated | CharactHer. ICORG 12-09, V3 HER2-positive Breast Cancer, TNM Stage II-IV Breast Cancer | — | 2012-07-01 |
| Completed | A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer Metastatic Breast Cancer | Phase 3 | 2012-02-13 |
| Terminated | Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4 Colorectal Cancer, Non-Small Cell Lung Cancer | — | 2011-05-01 |
| Completed | Circulating miRNAs. Breast Cancer, Newly Diagnosed Breast Cancer, Recurrent Breast Cancer | — | 2011-05-01 |
| Completed | Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5 Renal Cell Carcinoma | Phase 2 | 2011-03-01 |
| Terminated | The Myocet/Lapatinib Study. ICORG 10-03, V5 Her2 Positive Metastatic Breast Cancer | Phase 1 / Phase 2 | 2011-03-01 |
| Completed | A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carb Breast Cancer | Phase 2 | 2010-10-01 |
| Completed | Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Lung Cancer | N/A | 2010-06-01 |
| Terminated | Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimension Endometrial Cancer, Gastrointestinal Complications, Radiation Toxicity | Phase 2 | 2010-03-01 |
| Completed | Tarceva. ICORG 08-41 Non-small Cell Lung Cancer | — | 2009-12-01 |
| Withdrawn | Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small C Lung Cancer | Phase 1 | 2009-11-01 |
| Completed | Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2 Metastatic Cancer, Prostate Cancer | — | 2009-11-01 |
| Terminated | 3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Tre Breast Cancer | N/A | 2009-10-01 |
| Active Not Recruiting | A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 Prostate Cancer | Phase 2 | 2009-07-20 |
| Terminated | Blood Biomarker Signature in Glioma Glioma of Brain | — | 2009-07-01 |
| Completed | Sorafenib. ICORG 06-41, V4 Esophageal Cancer, Gastric Cancer | Phase 2 | 2009-02-01 |
| Completed | Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2009-01-01 |
| Completed | TC Avastin. ICORG 08-10, V6 Breast Cancer | N/A | 2008-10-01 |
| Completed | Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia Leukemia | Phase 2 | 2008-10-01 |
| Completed | CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7 Leukemia | Phase 2 | 2008-08-18 |
| Completed | Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer | — | 2008-08-01 |
| Completed | CADY Study ICORG 08-01 Breast Cancer, Cardiac Toxicity | — | 2008-04-01 |
| Completed | Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head Head and Neck Cancer | N/A | 2008-01-01 |
| Completed | Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 Breast Cancer | Phase 1 | 2007-10-01 |
| Completed | Spinal Cord Compression Re-Treat Study Pain, Radiation Toxicity, Spinal Cord Compression | Phase 2 | 2007-10-01 |
| Completed | Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma Melanoma (Skin) | Phase 2 | 2007-08-01 |
| Completed | A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in Gastro Oesophageal Cancer | Phase 2 | 2007-05-01 |
| Terminated | Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimension Lung Cancer, Metastatic Cancer | Phase 2 | 2007-03-01 |
| Completed | Bortezomib in Treating Patients With Malignant Pleural Mesothelioma Malignant Mesothelioma | Phase 2 | 2006-05-01 |
| Completed | Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prost Prostate Cancer | N/A | 2006-03-01 |
| Unknown | Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormo Prostate Cancer | — | 2006-02-01 |
| Completed | Spinal Cord Compression. ICORG 05-03, V6 Spinal Cord Compression, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | 2006-01-01 |
| Completed | PAD. ICORG 05-01, V11 Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2005-12-01 |
| Completed | Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, Lung Cancer | Phase 2 | 2000-11-01 |